SYN-006 (Synthetic Biologics/SynPhaGen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSYN-006 (Synthetic Biologics/SynPhaGen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase modulatorsMicrobiome modulators
TargetsBeta Lactamase
Therapy Area/IndicationsDiarrheaClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheriva Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynphagen LlcTheriva Biologics Inc
Active IndicationsN/A
Inactive IndicationsDiarrheaClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A